Radiotherapy benefits last a decade, breast cancer study reveals
Providing radiotherapy after surgery could prevent breast cancer from returning in the same place for up to 10 years, a long-term study suggests.
Aug 7, 2024
0
38
Providing radiotherapy after surgery could prevent breast cancer from returning in the same place for up to 10 years, a long-term study suggests.
Aug 7, 2024
0
38
University of Pittsburgh and UPMC Hillman Cancer Center researchers have developed a novel prompt, or 'nudge' embedded in the electronic health record that flags, for treating surgeons, older patients with early-stage breast ...
Jul 17, 2024
0
0
Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma (CCA). This cancer is ...
Jun 20, 2024
0
0
Early resistance exercise following surgery for early-stage breast cancer improves shoulder range of motion (ROM) and strength at one month and six months postsurgery, according to a study published online June 5 in JAMA ...
Jun 7, 2024
0
0
Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly ...
Jun 4, 2024
0
0
A UCLA-led study suggests that women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
May 10, 2024
0
33
Breast-conserving surgery (BCS), also called lumpectomy, involves the removal of a cancerous lump and some surrounding tissue. BCS is suitable for women with early-stage breast cancer or small lumps, as it preserves more ...
May 9, 2024
0
39
Using a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial presented at the 14th European Breast Cancer Conference.
Mar 20, 2024
0
1
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizumab to chemotherapy before and after surgery for breast cancer leads to better outcomes for patients regardless of their ...
Mar 19, 2024
0
1
For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
67